RSS

AstraZeneca

Biotechnology company Aptamer Group is collaborating with AstraZeneca to develop drug delivery devices targeting the kidney. Read more

News

Why Manchester is set to become a global medtech player Massachusetts-style Read more

Opinion 1 Comments